Galmed pharmaceuticals announces proposed offering of ordinary shares

Tel aviv, israel, feb. 16, 2021 /prnewswire/ -- galmed pharmaceuticals ltd. (nasdaq: glmd) ("galmed" or the "company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced that it is commencing an underwritten public offering of its...
GLMD Ratings Summary
GLMD Quant Ranking